Lynch syndrome patient with metastatic colon cancer, later found to have localized urothelial cancer. Absent/lacking MSH-2 and MSH-6 expression in both tumors. The patient was treated with PEMBRO for 9 mo, ATEZO for 8 mo until PD prior to dual-immunotherapy. This evidence concerns the gene MSH6 and Lynch syndrome.